Claim Missing Document
Check
Articles

Found 26 Documents
Search

UJI AKTIVITAS EKSTRAK ETANOL KULIT ARI BUAH JENGKOL (Pithcelobium jiringa) SEBAGAI BIOLARVASIDA NYAMUK (Aedes aegypti L.) Noverda Ayuchecaria; Nida Munirah; Amaliyah Wahyuni; Eka Kumalasari; Ratih Pratiwi Sari; Siska Musiam
Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Vol 4 No 1 (2019): JIIS
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (124.787 KB) | DOI: 10.36387/jiis.v4i1.288

Abstract

Larvasida is still the first line in the prevention of Dengue Hemorrhagic Fever (DHF) disease caused by Aedes aegypti L. mosquitoes. Indonesia itself as a tropical country has many beneficial plants, one of which is Pithcelobium jiringa pericarp. Until now, the use of pericarp is still lacking even though jengkol fruit peels contain secondary metabolites such as flavonoids, saponins, tannins and triterpenoids, which have larvacidal effects. The purpose of this study was to determine the activity of ethanol extract of Pithcelobium jiringa pericarp as biolarvasida of Aedes aegypti L. mosquitoes from LC50 values. The treatment concentration used in this study was concentrations of 10%, 30%, and 50%. Temephos 1% is used as a positive control. The concentration was then tested on 20 Aedes aegypti L. larvae. The results showed that there was a treatment effect (sig <0.05) on the number of larval deaths, which from the results of Tuckey's analysis showed that 30% and 50% concentrations and 1% Temephos showed significant differences in the number of test larvae deaths. The results showed that the extract was effective as biolarvasida of Aedes aegypti L. mosquitoes. The results of probit analysis showed LC50 extract to Aedes aegypti L. larvae was 20.4716% which is a low toxin group in aquatic environments.
COMPARISON THE REAL COST WITH INA-CBG’S PACKAGE TARIFF AND ANALYSIS ON THE FACTORS INFLUENCING THE REAL COST FOR DIEBETES MELLITUS INPATIENTS USING JAMKESMAS IN RSUP Dr. SARDJITO YOGYAKARTA Ratih Pratiwi Sari; Fita Rahmawati; I Dewa Putu Pramantara
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 3, No 1
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.95

Abstract

The problem usually found in the Jamkesmas (Society Health Insurance) realization is the difference between the real cost and INA-CBGs package tariff for patients using Jamkesmas, especially in inpatient department. This study was to find out how much the margin between the real cost and the INA-CBG’s package tariff and the factors influence the real cost, and to know the suitability of drug indications in diabetes mellitus inpatients using Jamkesmas in RSUP Dr. Sardjito Yogyakarta. This study was analytical observation. The data were taken retrospectively from the Jamkesmas claim files and patients’ medical record. Subjects were patients with diabetes mellitus type 2.The research object included the claim files and the medical record of the diabetes mellitus patients using Jamkesmas in RSUP Dr. Sardjito Yogyakarta during period of July 2010 – May 2012 with the diagnosis code INA-CBGs E-4-10-I, E-4-10-II, and E-4-10-III. The data were analyzed descriptively. Moreover, One sample test statistical analysis was conducted to find the difference between the real cost and INA-CBGs tariff and the ifference between hospital LOS and INA-CBGs package LOS. In addition,bivariate correlation test and regression linier test were used to study the relation among the factors that affect the real cost. The result of the study showed that the difference between the real costand INA-CBGs package tariff of the diabetes mellitus Jamkesmas patients with the severity level I was Rp 5,325,126 in 2 episodes of cares; severity level II was Rp -22,411 in 10 episodes of care, and severity level III was Rp -3,038,240 in 12 episodes of care. The factors that affect the real cost of treatment of patients with the severity level II were cost of clinical pathology examination, blood, and drug/medical cost, while in patient with severity level III werethe cost of visite, service in dialysis department, clinical pathology examination and drug/medical cost. From the analysis between the used drug and indication, it was found that 22 episodes of care was appropriate with the diagnosis and 2 episodes of care was not fit with the diagnosis.Keywords: Jamkesmas, INA-CBG’s, diabetes mellitus, cost components, indication of suitability
Combination of Bawang Dayak Extract and Acarbose against Male White Rat Glucose Levels Aditya Maulana Perdana Putra; Ratih Pratiwi Sari; Siska Musiam
Borneo Journal of Pharmacy Vol. 4 No. 2 (2021): Borneo Journal of Pharmacy
Publisher : Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33084/bjop.v4i2.1703

Abstract

Diabetes is a chronic metabolic disease with signs of increased blood glucose levels. Type 2 diabetes is common diabetes in adults. Bawang dayak is one of the plants believed to have the efficacy of curing various types of diseases. The purpose of this study was to find out the comparison of hypoglycemic effects between combinations of bawang dayak extract and acarbose with single acarbose. This study was an experimental study using 32 white mice divided into two groups. Group one was given a combination of bawang dayak at a dose of 100 mg/kg BW and acarbose at a dose of 40 mg/100 g BW, while group two was given acarbose at a dose of 40 mg/100 g BW. Treatment is administered after the test animal is induced with dexamethasone at a 1 mg/kg BW dose dissolved in NaCl 0.9% subcutaneously for 12 days. Measurement of glucose levels was carried out using a glucometer. Data retrieval was carried out every three days for 15 days after previously fulfilled for +10 hours. Blood glucose level data were analyzed with the General Linear Model test. The combination of bawang dayak-acarbose onion extract had a greater decrease in blood glucose levels than single acarbose. Average reduction in blood glucose levels for D+3; D+6; D+9; D+12; and D+15 was 187.31; 168.56; 140.81; 119.81; and 102.56 mg/dl, respectively. The General Linear Model test results showed a p <0.05 value that significantly impacted blood glucose levels between groups.
IDENTIFIKASI DAN PENETAPAN KADAR RHODAMIN B PADA KUE BERWARNA MERAH DI PASAR ANTASARI KOTA BANJARMASIN Ratih Pratiwi Sari
Jurnal Ilmiah Manuntung Vol 1 No 1 (2015): Jurnal Ilmiah Manuntung
Publisher : jurnal ilmiah manuntung sekolah tinggi ilmu kesehatan samarinda

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51352/jim.v1i1.16

Abstract

Rhodamine B is a synthetic dye used to dye the textile industry. Rhodamine B is presence in food can cause poisoning, skin irritation, lung irritation, eye irritation, throat irritation, nasal irritation, and cause liver damage if exposed to high concentrations. Samples taken from the red cake seller in the Antasari Banjarmasin market. This research is a descriptive study. The sampling technique used was accidental sampling. Rhodamine B on a method of identification of samples using Thin Layer Chromatography and Visible spectrophotometry. Samples were prepared using the absorption method wool. The resulting solution will be used as identification in Thin Layer Chromatography using silica gel GF 254 plates with a mobile phase of n-butanol : ethyl acetate : ammonia (10:4:5). Rhodamine B assay performed visible spectrophotometry at a wavelength of 544 nm.Results of identification were putri ayu cake, Apam cake, Kukus cake A, Bolu cake, Singkong cake, and Kukus cakes B, shows that 1 positive samples containing Rhodamine B is a Apam cake. After that, the assay of Rhodamine B was performed in the sample apam  cake and obtained for 0,4229 ± 0,1157 mg of Rhodamine B in 1 piece of red cake
HUBUNGAN PENGETAHUAN DAN KEBUTUHAN PASIEN TERHADAP INFORMASI OBAT DI APOTEK AMANDIT FARMA BANJARMASIN Ratih Pratiwi Sari; Aditya Maulana Perdana Putra; Ulfah Masran
Jurnal Ilmiah Manuntung Vol 4 No 2 (2018): Jurnal Ilmiah Manuntung
Publisher : jurnal ilmiah manuntung sekolah tinggi ilmu kesehatan samarinda

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51352/jim.v4i2.188

Abstract

The current pharmaceutical service has shifted its orientation from drug oriented to patient oriented with reference to pharmaceutical care. Pharmaceutical service activities are not limited to drug preparation and drug delivery to patients but pharmacy needs to interact or communication with the patient. The purpose of this study was to determine how is the relationship between knowledge and patient needs for drug information at Amandit Farma Pharmacy Banjarmasin. This type of research is descriptive analysis. Sampling was taken on March 9 - April 8, 2018 by giving questionnaires to 250 patients who redeemed the prescription at Amandit Farma Banjarmasin Pharmacy using systematic random sampling method according to exclusion and inclusion criteria. Data analysis using Chi Square 3x3. Based on the results of this study can be known the relationship between knowledge and needs of patients on drug information at Amandit Farma Pharmacy in Banjarmasin is statistically meaningful
PROFIL KUALITAS HIDUP DAN TEKANAN DARAH PASIEN HIPERTENSI RAWAT JALAN DI RSUD ULIN BANJARMASIN Riza Alfian; Nani Lisdawati; Aditya Maulana Perdana Putra; Ratih Pratiwi Sari; Fahma Lailani
Jurnal Ilmiah Manuntung Vol 4 No 2 (2018): Jurnal Ilmiah Manuntung
Publisher : jurnal ilmiah manuntung sekolah tinggi ilmu kesehatan samarinda

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51352/jim.v4i2.189

Abstract

Hypertension is one of the main factors of coronary heart disease and stroke. The prevalence of hypertension in South Kalimantan Province occupied a second prevalence of 30,8%. Hypertension is a chronic disease that requires long-term treatment. Furthermore, long-term treatment of anti-hypertension patients also have the possibility of side effects that also affect the quality of life of patients. Uncontrolled blood pressure can aggravate the incidence of hypertension and develop into a more dangerous disease that affects the quality of life of patients. The purpose of this study was to determine the description of blood pressure and quality of life of outpatient hypertensive patients at RSUD Ulin Banjarmasin. This research was conducted by using survey method. Sampling was done by consecutive sampling method. Samples meeting the inclusion criteria were 61 patients. The sample inclusion criteria were outpatients ages 18-65 with hypertension diagnoses, and were willing to follow the study. Exclusion criteria were patients with uncooperative, illiterate and deaf conditions. Data collection was done by interviewing and filling out the EQ-5D questionnaire. Blood pressure data were taken from medical records. The data of the research are presented in descriptive form. Based on this research can be concluded that the value of systolic blood pressure and diastolic mean of research sample is 153,82 ± 17,62 and 86,16 ± 10,52 mmHg. The study sample was dominated by patients with level II hypertension (52,5%). Furthermore the quality of life of the average sample was dominated by the category of poor quality of life (73,8%).